GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Lophos Holdings Inc (XCNQ:MESC) » Definitions » FCF Yield %

Lophos Holdings (XCNQ:MESC) FCF Yield % : 0.00 (As of Apr. 23, 2025)


View and export this data going back to 2023. Start your Free Trial

What is Lophos Holdings FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Lophos Holdings's Trailing 12-Month Free Cash Flow is C$-0.94 Mil, and Market Cap is C$0.88 Mil. Therefore, Lophos Holdings's FCF Yield % for today is 0.00%.

The historical rank and industry rank for Lophos Holdings's FCF Yield % or its related term are showing as below:


XCNQ:MESC's FCF Yield % is not ranked *
in the Biotechnology industry.
Industry Median: -15.17
* Ranked among companies with meaningful FCF Yield % only.

Lophos Holdings's FCF Margin % for the quarter that ended in Mar. 2024 was 0.00%.


Lophos Holdings FCF Yield % Historical Data

The historical data trend for Lophos Holdings's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lophos Holdings FCF Yield % Chart

Lophos Holdings Annual Data
Trend Mar22 Mar23 Mar24
FCF Yield %
- - -18.30

Lophos Holdings Quarterly Data
Dec21 Mar22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
FCF Yield % Get a 7-Day Free Trial Premium Member Only - - -18.98 -38.90 -25.16

Competitive Comparison of Lophos Holdings's FCF Yield %

For the Biotechnology subindustry, Lophos Holdings's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lophos Holdings's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Lophos Holdings's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Lophos Holdings's FCF Yield % falls into.


;
;

Lophos Holdings FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Lophos Holdings's FCF Yield % for the fiscal year that ended in Mar. 2024 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-0.943 / 5.1516
=-18.30%

Lophos Holdings's annualized FCF Yield % for the quarter that ended in Mar. 2024 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-0.324 * 4 / 5.1516
=-25.16%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Lophos Holdings FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Lophos Holdings FCF Yield % Related Terms

Thank you for viewing the detailed overview of Lophos Holdings's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Lophos Holdings Business Description

Traded in Other Exchanges
N/A
Address
1111 Melville Street, Suite 620, Vancouver, BC, CAN, V6E 3V6
Website
Lophos Holdings Inc is engaged in the y is the cultivation of peyote and the manufacture of Lophophora compounds, including Mescaline, as well as formulation of novel Lophophora-based compounds.
Executives
John Ioannis Karagiannidis Director
Evan Stawnyczy Director

Lophos Holdings Headlines

No Headlines